Search Results

Pharmacogenetic aspects of efficacy and safety of methotrexate treatment in pediatric acute lymphoblastic leukemia.

• Authors : Gurieva OD; Department of Pediatric Oncology and Hematology Research Institute, N.N. Blokhin National Medical Research Cancer Center of the Ministry of Health of Russia, Moscow, Russia.; Savelyeva MI

Subjects: Methotrexate*/Methotrexate*/Methotrexate*/adverse effects ; Precursor Cell Lymphoblastic Leukemia-Lymphoma*/Precursor Cell Lymphoblastic Leukemia-Lymphoma*/Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy ; Precursor Cell Lymphoblastic Leukemia-Lymphoma*/Precursor Cell Lymphoblastic Leukemia-Lymphoma*/Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics

• Source: Drug metabolism and personalized therapy [Drug Metab Pers Ther] 2023 Dec 14; Vol. 38 (4), pp. 349-357. Date of Electronic Publication: 2023 Dec 14 (Print Publication: 2023).Publisher: De Gruyter Country of Publication: Germany NLM ID: 101653409 Publication Model: eCollection Cited Medium:

Record details

The 10+1 Santorini Conference.

Subjects: PHARMACOGENOMICS; WEIGHT gain; BLOOD platelet aggregationSANTORINI Island (Greece)

• Source: Clinical Chemistry & Laboratory Medicine; May2024, Vol. 62 Issue 6, peA1-eA43, 43p

Record details

Not all geriatric cachexia is cancer – The difficult lateonset rheumatoid arthritis.

• Authors : Correia, Ana Rubim; Clara, Inês; Martins, Sara Raquel

Subjects: RHEUMATOID arthritis; CACHEXIA; MEDICAL personnel

• Source: Rheumatology & Immunology Research; Mar2024, Vol. 5 Issue 1, p68-71, 4p

Record details

Methotrexate related cutaneous adverse drug reactions: a systematic literature review.

• Authors : Zuber, Mohammed; Harikrishna; Vidhyashree

Subjects: THERAPEUTIC use of folic acid; STEROID drugs; ONLINE information services

• Source: Journal of Basic & Clinical Physiology & Pharmacology; Sep2022, Vol. 33 Issue 5, p549-565, 17p

Record details

The Choosing Wisely initiative and laboratory test stewardship.

• Authors : Baird, Geoffrey S.

Subjects: MEDICAL care costs; WASTE minimization; PHYSICIANSUNITED States

• Source: Diagnosis (2194-802X); Mar2019, Vol. 6 Issue 1, p15-23, 9p

Record details

The use of liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of antibiotics in cancer patients.

• Authors : Jantsch, Jonathan; Gessner, André; El-Najjar, Nahed

Subjects: ANTIBIOTICS; CANCER patients; LIQUID chromatography-mass spectrometry

• Source: Clinical Chemistry & Laboratory Medicine; Sep2017, Vol. 55 Issue 9, p1246-1261, 16p

Record details

Head to head evaluation of the analytical performance of two commercial methotrexate immunoassays and comparison with liquid chromatography-mass spectrometry and the former fluorescence polarization immunoassay.

• Authors : Günther, Viola; Mueller, Daniel; von Eckardstein, Arnold

Subjects: METHOTREXATE; DRUG monitoring; LIQUID chromatography-mass spectrometry

• Source: Clinical Chemistry & Laboratory Medicine; May2016, Vol. 54 Issue 5, p823-831, 9p

Record details

Congress Abstracts/Second ESPT Conference 'Pharmacogenomics: From Cell to Clinic'.

• Source: Drug Metabolism & Drug Interactions; Aug2013, Vol. 28 Issue 3, pA1-A48, 48p

Record details

Cancer/tumour markers.

Subjects: BLOOD lipoproteins; LIPOCALIN-1; BREAST cancer

• Source: Clinical Chemistry & Laboratory Medicine; Jun2009 Supplement, Vol. 47, pS154-S174, 21p

Record details

The relevance of therapeutic drug monitoring in plasma and erythrocytes in anti-cancer drug treatment.

• Authors : Dumez, Herlinde; Guetens, Gunther; De Boeck, Gert

Subjects: DRUG monitoring; PATIENTS; BLOOD cells

• Source: Clinical Chemistry & Laboratory Medicine; Nov2004, Vol. 42 Issue 11, p1219-1227, 9p

Record details